Investigating the impact of metformin on severity of COVID‐19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings

BACKGROUND: In the terrifying pandemic caused by SARS‐CoV‐2, diabetic patients exhibiting more severe outcomes and mortality rate is high among them. Based on recent studies, metformin as the most prescribed drug for T2DM treatment may improve severe outcomes in diabetic patients infected with SARS‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri, Rana, Shahrokhi, Seyedeh Zahra, Amjadi, Zahra, Kazerouni, Faranak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495547/
https://www.ncbi.nlm.nih.gov/pubmed/37431844
http://dx.doi.org/10.1002/edm2.441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495547/
https://www.ncbi.nlm.nih.gov/pubmed/37431844
http://dx.doi.org/10.1002/edm2.441

Ejemplares similares